 Objectives / Deliverables  Strategy  Ideas  First Results  Recent and Next Steps G&H Meeting 22-26 th April, 2002 Leipzig, Germany WP 7 Pharmaceutics.

Slides:



Advertisements
Similar presentations
VTM Virtual Therapeutic Moeity Actual Therapeutic Moeity ATM VMP Virtual Medicinal Product AMP Actual Medicinal Product AMPP Actual Medicinal Product Package.
Advertisements

 AUTHOR- Musiba Baliruno Denis, B.pharm (MUST) SUPERVISORS ;  Prof. K.A.M. Kuria, PhD - Department of Pharmaceutics and Pharmacy Practice, University.
2-5. Formulation Development Issues: Solid Orals Satish Mallya January, 2011.
By Timina Olive Kayaviri Supervisor : Dr. Amugune
Chemistry, Manufacturing, and Controls (CMC) and Good Manufacturing Practices (GMPs): The Big Picture of a Long-term Commitment Elizabeth Pollina Cormier,
Free Powerpoint Templates Page 1 Mohammad Khalid Anwer, Ph.D - Mohammad Khalid Anwer, Ph.D -
FORMULATION OF A FAST-DISSOLVING KETOPROFEN LYOPHILIZED TABLET
VINOD P. SHAH, PH.D. SENIOR RESEARCH SCIENTIST OFFICE OF PHARMACEUTICAL SCIENCE CENTER FOR DRUG EVALUATION AND RESEARCH FOOD AND DRUG ADMINISTRATION Pharmacy.
Nahla S Barakat, PhD Professor of Pharmaceutics 8/18/2015 PHR Principles and kinetics of drug stability (PHR 416)
The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific.
Factors Affecting Drug Absorption (Pharmaceutical factor)
© NextPharma Technologies 2006 NextPharma Technologies Experts in the production of Pellets.
ENVIROPAK WP5. Development of coating Techniques (Maida Khan, Borges Chambal, Asmina Sulemane, Izdine Opressa, Sandra Chemane and Silvia Abdula) November.
Improved Tablet  Focus on stability  Focus on reasonable production  Focus on packaging material High-End Tablet  Vision?! Study Medication  Focus.
1-7.The ICH Q8 “Minimal Approach” to Pharmaceutical Development
Novel Multifunctional Excipients by Co-processing with Mg-Silicate Dr. Faisal Al-Akayleh Faculty of Pharmacy, Petra University.
1.  Drug delivery is the method or process of administering pharmaceutical compound to achieve a therapeutic effect in humans or animals.  Most common.
Stability of FPPs- Conducting, Bracketing, Matrixing Sultan Ghani.
1 Abu Alam Ph.D. Advisory Committee for Pharmaceutical Science and Clinical Pharmacology July 23, 2008.
Cellular Respiration. I. What is Cellular Respiration?  Cellular Respiration is the series of reactions by which organisms obtain energy by breaking.
Excipient Composition and Performance-Related Properties of Excipients Chris Moreton, Ph.D. FinnBrit Consulting IPEC-Americas FDA Seminar, October 21,
Satish Mallya January 20-22, |1 | 2-3. Pharmaceutical Development Satish Mallya Quality Workshop, Copenhagen May 18-21, 2014 May 18-21,2014.
The Pharmaceutical Composition Methodology described in this presentation has been developed to improve controlled drug delivery through site specific.
Study Medication  Time schedule  Résumé Development of an improved tablet formulation  Long term stability  Reasonable production conditions  Focus.
DH 29  Development of analytical methods DH 30  Analysis of EU market products DH 33  Development of a novel tablet DH 36  Preparation of study medication.
Formulation, Characterization of Pellets of Duloxetine Hydrochloride by Extrusion and Spheronization Prof. V. R. Sinha University Institute of Pharmaceutical.
1 G&H Meeting 4-5 th October, 2001 G&H Meeting 4-5 th October, 2001 Wellesbourne, UK Wellesbourne, UK WP 7 Pharmaceutics WP 7 Pharmaceutics Objectives.
Odile Huchette, research engineer Christèle Bellamy, research technician Didier Perrin, research assistant G&H October 2002, Montpellier WP3 / cultivation,
Using Product Development Information to Address the Bioequivalence Challenges of Highly-variable Drugs Lawrence X. Yu, Ph. D. Director for Science Office.
Tablets coating.
Bioavailability of Dietary Supplements: Key Issues in Defining the Research Agenda Impact of Formulation on Bioavailability? Discussion Leader: Stephen.
ABOUT OUR NEW HPLC METHOD  We have identified a new compound in garlic HPLC profile, the S-allyl cystein (SAC) that has a potential therapeutic activity.
Solid dosage forms Tablets
Suad Y. Alkarib 1 Dina Elraih 2 Waddah F. Nour 3.
 Objectives Improved Tablet  focus on stability  focus on low costs High-End Tablet  maximum dose  controlled release G&H Meeting 1-2 October, 2002.
Quality Assurance of Medicines under Universal Health Coverage Program by Siriwat Tiptaradol (Presenter) Duangporn Abhigantaphand Sooksri Ungboriboonpisal.
PRODUCTION PACKAGING DISTRIBUTION CONSUMPTION Food packaging has a key role to play The complex single operation of placing food or a beverage in a container.
Physical Testing 1.Solutions 2.Disperse systems 3.Aerosols 4.Powders 5.Tablets 6.Sustained release products 7.Coated tablets 8.Hard & soft shell capsules.
April 12, 09 A. Saffari, PH.D Former WHO Technical Officer
- Pharmaceutical Equivalence Study
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
Solid dosage forms Tablets
PRINCIPLES OF PHARMACEUTICAL FORMULATION AND DOSAGE FORM DESIGN:
Gastrointestinal Absorption: Role of the Dosage Form
Biopharmaceutics of modified release drug products
Evaluation of tablet Lab 5.
WHO Technical Report Series, No. 953, 2009
Evaluation of tablet Lab 5.
Biopharmaceutic Considerations in Drug Product Design
Novel Drug Delivery System
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
HHM 5014 NUTRACEUTICAL FORMULATION TECHNOLOGY
FARHANA AMIRAH NADIA AMIR
Lab -7- Capsules.
VACCUM PACKAGING AND MODIFIED ATMOSPHERE PACKAGING AND STORAGE
Pharmacokinetics: Drug Absorption
LAB.2 Tablet Production Methods
Objectives… G&H Meeting February, 2003 Liverpool, UK
Lab -7- Capsules.
Second Level Pharmacy Students
Lab. 2 Industrial pharmacy
Evaluation of tablet Lab 5.
9.6 Solving Rational Equations
Practical Pharmaceutical Orientation
RingCap Technology Mrs. Maria Saifee Associate Professor,
Fenofibrate USP (Micronized, control)
© 2016 Global Market Insights, Inc. USA. All Rights Reserved Offset Ink Market Size will witness a rapid growth to 2025.
Presentation transcript:

 Objectives / Deliverables  Strategy  Ideas  First Results  Recent and Next Steps G&H Meeting th April, 2002 Leipzig, Germany WP 7 Pharmaceutics (Lichtwer Pharma)

Objectives / Deliverables Objectives / Deliverables  Development of an improved pharmaceutical formulation Garlic of the future!

Objectives / Deliverables Objectives / Deliverables  Improved pharmaceutical formulation  Quality  Stability  Quantity of release  Release profile  Costs  Consumer attraction (look, “story”)  Consumer compliance (odour, size)

Objectives / Deliverables Objectives / Deliverables  Low costs  Poor and unpredictable quality  Unstable  Uncontrolled release profile  Steadily decreasing consumer attraction  Moderate consumer compliance  Market products

Objectives / Deliverables Objectives / Deliverables  Where to improved?  Quality  Stability  Quantity of release  Release profile  Costs  Consumer attraction  Consumer compliance

Strategy Strategy  “Economic” Approach  Quality  Stability  Controlling of costs  “High End” Approach  Quality  Stability  Quantity of release  Release profile  Consumer attraction  Consumer compliance  Two Approaches for Improvements

Strategy Strategy  Garlic Powder  Content active substances  Higher microbial purity  Results from Garlic&Health project?  Finished Product  Optimised packaging  “Nothing else to do?!”  Economic Approach – Quality

Strategy Strategy  Garlic Powder  Dryer Powder < 1 % residual water)  Pre-Formulation of Garlic Powder Granulation, Micro-capsulation  Finished Product  Processing under dryer conditions process under air condition  Enhanced Protection from Humidity  Enhanced Protection from Oxygen enhanced packaging material  Economic Approach – Stability

Ideas Ideas  Economic Approach – Comparison  Dragee (Market Standard)  100 mg Garlic powder  15 – 20 Excipients  Production time:  24 h  Film coated tablet  100 mg Garlic powder  7-8 Excipients  Production time:  8 h

First results First results  Film coated tablet containing pre-dried ingredients I

First results First results  Film coated tablet containing pre-dried ingredients II

Strategy Strategy  Garlic Powder  Higher alliin content  Combination of powder and alliin rich extract (= substrate for alliinase)  Finished Product  Protection of alliinase from inactivation in acid gastric media  up-concentrating of alliin in the “neighbourhood“ of alliinase  “High End” Approach – Quantity of Release

Strategy Strategy  Garlic Powder  Pre-formulation of garlic powder for prolonged release of alliinase products  Finished Product  Matrix-, compartment tablets creating a prolonged release profile ...combined with alliin rich extract (substrate for alliinase)  “High End” Approach – Release Profile

Strategy Strategy  Garlic Powder  “Higher dosis” declarated  “The story behind” European garlic with a research background  Finished Product  More efficacy – less side effects (odour)  (Self) explaining product “one can see what one get and how it works”, “yes it’s different from the usual”  “High End” Approach –Consumer Attraction Consumer Compliance

= Alliinase containing garlic powder Ideas Ideas  High End Approach – functionalised tablet = Alliin rich garlic extract = Inner coating = Outer coating mm mm

Recent and Next Steps Recent and Next Steps  On-going stability tests on pre-dried formulation  Lab experiments to gain an alliin up- concentrated extract  Technical production of an alliin enriched extract  Orientating and lab scale galenic experiments for a new dosage form  “What’s going on at Lichtwers...?”